Dr Reddys Laboratories (RDY) Net Margin Growth (3y) (2012 - 2023)
Dr Reddys Laboratories (RDY) Net Margin Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 948.00 |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 83.00 |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | -94.00 |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | -990.00 |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | -604.00 |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 1,312.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.19 Bn | 7.53 Bn | 397.90 Mn | -3,829.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -71.00 |
| Mar 31, 2023 | 769.00 |
| Jun 30, 2021 | 408.00 |
| Mar 31, 2021 | -67.00 |
| Sep 30, 2020 | -2,472.00 |
| Sep 30, 2019 | -2,758.00 |
| Mar 31, 2019 | 58.00 |
| Dec 31, 2018 | -251.00 |
| Sep 30, 2018 | -212.00 |
| Jun 30, 2018 | -489.00 |
| Dec 31, 2017 | -484.00 |
| Sep 30, 2017 | -735.00 |
| Dec 31, 2016 | -809.00 |
| Sep 30, 2016 | -296.00 |
| Mar 31, 2016 | 1,693.00 |
| Dec 31, 2015 | -377.00 |
| Sep 30, 2015 | -332.00 |
| Jun 30, 2015 | 203.00 |
| Dec 31, 2014 | 47.00 |
| Sep 30, 2014 | 1,604.00 |